FibroLief™ Comprehensive Anti-Fibroid & Hormone Balance Formula

Clinical Study Links for Fibrolief 

 

🔹 Core Anti-Fibroid & Anti-Inflammatory


1. EGCG (Green Tea) – RCT in women with uterine fibroids

https://pubmed.ncbi.nlm.nih.gov/23950663/

 

2. Curcumin – Double-blind RCT for primary dysmenorrhea

https://pubmed.ncbi.nlm.nih.gov/31379270/

 

3. Boswellia serrata (5-Loxin®) – Randomized, double-blind OA pain RCT

https://pubmed.ncbi.nlm.nih.gov/24669233/

 

4. Serrapeptase – Randomized, placebo-controlled post-op swelling RCT

https://pubmed.ncbi.nlm.nih.gov/6366803/

 

5. Nattokinase – Randomized, double-blind trial on blood pressure

https://pubmed.ncbi.nlm.nih.gov/18830039/

 

6. Quercetin – Randomized, placebo-controlled trial in PCOS

https://pubmed.ncbi.nlm.nih.gov/27280133/

 

7. Diindolylmethane (DIM) – Randomized study on estrogen metabolism modulation

https://pubmed.ncbi.nlm.nih.gov/28339746/

 

8. Indole-3-Carbinol (I3C) – Randomized, placebo-controlled trial in cervical dysplasia (CIN)

https://pubmed.ncbi.nlm.nih.gov/10868638/

 

🔹 Hormone Balance & Traditional Uterine Support


9. Vitex agnus-castus – Randomized, placebo-controlled RCT for PMS

https://pubmed.ncbi.nlm.nih.gov/11159568/

 

10. Flaxseed (lignans) – Phase III randomized, placebo-controlled hot-flash trial

https://pubmed.ncbi.nlm.nih.gov/21900849/

 

11. Milk Thistle (Silymarin) – Randomized, double-blind RCT in NAFLD

https://pubmed.ncbi.nlm.nih.gov/23532074/

 

12. Ceylon Cinnamon – Randomized, placebo-controlled RCT for primary dysmenorrhea

https://pubmed.ncbi.nlm.nih.gov/25505909/

 

🔹 Enhanced Nutrient & Support Matrix


13. Vitamin D3 – Double-blind RCT: vitamin D reduced fibroid size

https://pmc.ncbi.nlm.nih.gov/articles/PMC6619469/

 

14. N-Acetylcysteine (NAC) – Randomized trial improving endometriosis-related pain/endometrioma size

https://pubmed.ncbi.nlm.nih.gov/36981595/

 

15. Resveratrol – Randomized clinical trial as add-on to OCP for endometriosis-related pain

https://pubmed.ncbi.nlm.nih.gov/29264492/

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.